In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of GlycoMimetics Inc (NASDAQ: GLYC) was $0.15 for the day, up 4.02% from the previous closing price of $0.14. In other words, the price has increased by $4.02 from its previous closing price. On the day, 1.54 million shares were traded. GLYC stock price reached its highest trading level at $0.1659 during the session, while it also had its lowest trading level at $0.141.
Ratios:
Our analysis of GLYC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.48 and its Current Ratio is at 5.48. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 22, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $12.
Jefferies Upgraded its Hold to Buy on November 12, 2021, whereas the target price for the stock was revised from $3 to $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 08 ’24 when Invus Public Equities, L.P. sold 260,873 shares for $0.19 per share. The transaction valued at 50,009 led to the insider holds 6,317,565 shares of the business.
Invus Public Equities, L.P. sold 61,488 shares of GLYC for $11,197 on Aug 07 ’24. The 10% Owner now owns 6,578,438 shares after completing the transaction at $0.18 per share. On Aug 05 ’24, another insider, Invus Public Equities, L.P., who serves as the 10% Owner of the company, sold 164,523 shares for $0.19 each. As a result, the insider received 30,996 and left with 6,695,658 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLYC now has a Market Capitalization of 9679048 and an Enterprise Value of -12258235. For the stock, the TTM Price-to-Sale (P/S) ratio is 967.84 while its Price-to-Book (P/B) ratio in mrq is 0.48. Its current Enterprise Value per Revenue stands at -1225.823 whereas that against EBITDA is 0.301.
Stock Price History:
Over the past 52 weeks, GLYC has reached a high of $3.53, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is -11.48%, while the 200-Day Moving Average is calculated to be -88.87%.
Shares Statistics:
GLYC traded an average of 1.06M shares per day over the past three months and 559470 shares per day over the past ten days. A total of 64.39M shares are outstanding, with a floating share count of 59.08M. Insiders hold about 8.38% of the company’s shares, while institutions hold 35.62% stake in the company. Shares short for GLYC as of 1727654400 were 1637061 with a Short Ratio of 1.54, compared to 1724976000 on 1932208. Therefore, it implies a Short% of Shares Outstanding of 1637061 and a Short% of Float of 3.66.
